Search research articles
Contact Us
Filters
Showing results (21-30 of 103) with videos related to
Page
of 11
Sort By:
Respiratory Medicine
|
July 11, 2008
Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations
Gary T Ferguson, Antonio Anzueto, Richard Fei, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
November 11, 2017
In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution
Stephen Pham, Gary T Ferguson, Edward Kerwin, et al.
Advances in Therapy
|
May 29, 2020
Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO<sup>®</sup> and OTEMTO<sup>®</sup> Studies
Roland Buhl, Dave Singh, Alberto de la Hoz, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
November 18, 2020
Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
Gary T Ferguson, Asif Shaikh, Kay Tetzlaff, et al.
Journal of Asthma and Allergy
|
November 8, 2019
Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results
Gary T Ferguson, Jeremy Cole, Magnus Aurivillius, et al.
Respiratory Medicine
|
August 26, 2017
Efficacy and safety of glycopyrrolate/eFlow<sup>®</sup> CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials
Edward Kerwin, James F Donohue, Thomas Goodin, et al.
Pulmonary Pharmacology & Therapeutics
|
March 24, 2018
Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology
Gary T Ferguson, Colin Reisner, James Pearle, et al.
Therapeutic Advances in Respiratory Disease
|
February 29, 2020
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials
Sanjay Sethi, James F Donohue, Gary T Ferguson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 3, 2011
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
Douglas W Mapel, Anand A Dalal, Christopher M Blanchette, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 3, 2018
Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
Gary T Ferguson, Roberto Rodriguez-Roisin, Colin Reisner, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 103) with videos related to
Sort By:
Page
of 11
Respiratory Medicine
|
July 11, 2008
Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations
Gary T Ferguson, Antonio Anzueto, Richard Fei, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
November 11, 2017
In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution
Stephen Pham, Gary T Ferguson, Edward Kerwin, et al.
Advances in Therapy
|
May 29, 2020
Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO<sup>®</sup> and OTEMTO<sup>®</sup> Studies
Roland Buhl, Dave Singh, Alberto de la Hoz, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
November 18, 2020
Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
Gary T Ferguson, Asif Shaikh, Kay Tetzlaff, et al.
Journal of Asthma and Allergy
|
November 8, 2019
Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results
Gary T Ferguson, Jeremy Cole, Magnus Aurivillius, et al.
Respiratory Medicine
|
August 26, 2017
Efficacy and safety of glycopyrrolate/eFlow<sup>®</sup> CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials
Edward Kerwin, James F Donohue, Thomas Goodin, et al.
Pulmonary Pharmacology & Therapeutics
|
March 24, 2018
Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology
Gary T Ferguson, Colin Reisner, James Pearle, et al.
Therapeutic Advances in Respiratory Disease
|
February 29, 2020
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials
Sanjay Sethi, James F Donohue, Gary T Ferguson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 3, 2011
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
Douglas W Mapel, Anand A Dalal, Christopher M Blanchette, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 3, 2018
Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
Gary T Ferguson, Roberto Rodriguez-Roisin, Colin Reisner, et al.
Page
of 11